(Q51765278)

English

Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up.

scientific article published on 23 February 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

borderline personality disorder

0 references

author name string

Marius K Nickel

1

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

Thomas H Loew

2

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

Francisco Pedrosa Gil

3

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

publication date

23 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

191

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

4

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

1023-1026

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0740-0

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0740-0

21 January 2018

Neurobiological mechanisms involved in antidepressant therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole for acute bipolar mania

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole pharmacotherapy of borderline personality disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17318503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-007-0740-0

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/17318503

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51765278&oldid=2211186169"